Henry Schein, Inc. earnings overview

HSIC FY2026 Q1 · Calendar Q2 2026

Henry Schein, Inc.

Henry Schein's Q1 FY2026 results demonstrate execution across multiple levers: 6.3% revenue growth led by U.S. dental and global technology, non-GAAP operating margin expansion to 7.53% from early value-creation benefits, and a strategic S.I.N. 360 acquisition deepening the implant portfolio. The 10% EPS beat and reaffirmed full-year guidance reflect management confidence in the path toward over $200M of operating-income improvement. Key watch items include margin sustainability amid rising freight costs, a light flu season dampening diagnostics demand, and the cadence of implant growth as the value-versus-premium mix evolves.